More of Fisher’s companies being taken over

A third company in portfolios run by Fisher Funds is now under a takeover bid, helping to boost returns.

Three of Fisher's funds, the International Growth Fund, the KiwiSaver Growth Scheme, and listed investment company Marlin Global, hold shares in US listed OSI Pharmaceuticals. 

OSI Pharmaceutical has received an unsolicited bid from Astellas, a Japanese pharmaceutical company of US$3.5billion, or US$52 per share, which is a more than 40% premium to the current market price. 

However, the stock closed yesterday above the takeover price, at US$56 per share. 

"There are other parties, such as Roche, who have an interest in acquiring the company.  Astellas has been pursuing OSI for more than a year now.  The price appreciation underscores the value in the franchise" Fisher Funds Senior Portfolio Manager Ken Applegate says. 

"We believe that merger and acquisition activity will be a significant contributor to investment returns during the 2010 year.  The global financial crisis saw companies hunker down and tidy up balance sheets, to the extent that many are now well placed to consider growth through acquisition."

In January the same three funds benefited from a 37% premium when the management of Chinese shoe retailer Hongguo acquired the company while Shiseido's acquisition of US company Bare Escentuals also brought a 40% premium to the funds a few days earlier in the same month.

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Printable version

Related News

KPMG report 'misleading' over cost of Marlin delisting and restructure: investor
Marlin Global shareholder lobbies for delisting, pans returns

Get quotes for Marlin Global Limited Ordinary Shares (MLN)

NZX Annoucements for MLN